Stock Taper
TNON
TENON MEDICAL, INC.
NASDAQ
$3.41
▼ DOWN 0.87% (-0.03)

KEY STATISTICS

Market Cap$1.71 M
52w High$50.40
52w Low$2.40
Dividend Yield—
Frequency—
P/E-0.08
Volume128.42K
Shares Out.496.46K

COMPANY

LEADERSHIP

Steven Foster
CHIEF EXECUTIVE
Steven Foster

ABOUT

SECTOR
Healthcare
WENT PUBLIC
April 27, 2022
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
26

PRICE TARGET

Target High$2.25
Target Low$2.25
Target Median$2.25
Target Consensus$2.25

UPCOMING EARNINGS

DateNov 12, 2026
DayThursday
Rev. Est.$1.43M
NOV
12
THU

SPLIT RECORD

DATETYPERATIO
2026-08-10Reverse1:35
2024-09-06Reverse1:8
2023-11-02Reverse1:10

ETFS HOLDING THIS STOCK

ETFS HOLDING
1
LISTED HERE
1
RANKED BY POSITION SIZE

PRICE

$3.41 ▼ DOWN 0.87% (−$0.03)
OVERLAYS
$3.40$3.44$3.489:30 AM10:35 AM11:40 AM12:44 PM1:49 PM2:54 PM3:59 PM3.41

About Tenon Medical, Inc.

https://www.tenonmed.com ↗

Tenon Medical, Inc. develops surgical implant systems, including the CATAMARAN SIJ Fusion System, to improve sacroiliac joint fixation and fusion outcomes, serving the U.S. and Puerto Rico since 2012.

INDUSTRY

Medical - Devices

A PRODUCT TENON MEDICAL, INC. IS KNOWN FOR

Catamaran SE SI Joint Fusion System
Catamaran SE SI Joint Fusion System

Tenon Medical's Catamaran SE is a minimally invasive SI joint fusion implant with a smaller profile, providing surgeons versatility for diverse anatomies and revisions in the expanding SI joint market.

Tenon Medical in 2025

SENTIMENT: + POSITIVE
Richard Ginn
REGULATORY · MARCH 2025

Tenon Medical Stock Skyrockets Over 300% Following Positive FDA and European Patent News

In March 2025, Tenon Medical experienced a massive stock surge of over 315% in a single day. This significant investor interest was fueled by two major positive developments: receiving FDA clearance for an expanded indication of its Catamaran SI Joint Fusion System for use as an augmentation to thoracolumbar fusion, and the grant of new patents by the European Patent Office for its Catamaran SI Joint Fixation Device.

ACQUISITION · Q2 2025 (ANNOUNCED SUBSEQUENT TO QUARTER END) · COMPLETED

Tenon Medical Acquires SiVantage to Diversify Product Offering and Reshape Commercial Strategy

In a pivotal strategic move, Tenon Medical completed the acquisition of SiVantage, a decision aimed at diversifying its product portfolio and expanding its commercial footprint. The company's leadership indicated this was a significant focus and led to a strategic shift in its commercial initiatives in anticipation of the deal's closing.

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

SECTORS PEERS

PEERPRICE
AEON$0.32COMPARE
SINT$2.12COMPARE
CLRB$1.44COMPARE
LFWD$6.21COMPARE
TRIB$5.90COMPARE
AEMD$6.03COMPARE
XAIR$2.43COMPARE
RDGT$0.89COMPARE

INSIDER TRADES

★
10 PERCENT OWNER
HRT FINANCIAL LP
Purchase · 28.3K shares
2026-09-10
★
10 PERCENT OWNER
HRT FINANCIAL LP
Purchase · 31.2K shares
2026-09-10
★
10 PERCENT OWNER
HRT FINANCIAL LP
Sale · 65.6K shares
2026-09-10
★
10 PERCENT OWNER
HRT FINANCIAL LP
Purchase · 8.4K shares
2026-09-10